Growth Hormone for the Treatment of Gastroparesis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions
Gastroparesis
Interventions
DRUG

Growth Hormone

"Subjects will receive growth hormone, Sogroya (Somapacitan-beco injections) via weekly injections for 12 weeks.~For males, the fixed dose will be 0.2 mg/day, 1.5 mg per week~For females, the fixed dose will be 0.3 mg/day, 2.1 mg per week"

Trial Locations (2)

85054

RECRUITING

Mayo Clinic, Phoenix

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06803589 - Growth Hormone for the Treatment of Gastroparesis | Biotech Hunter | Biotech Hunter